English

ALIMERA SCIENCES INC

EDGAR

ALIM Quarterly report (10-Q) · filed 2024-08-07

72 filing records in this dataset, filed from 2009-10-30 to 2024-08-07. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

27 million USD

2024 Q2 · USD

Exact inputs and evidence

Revenue: 27000000 USD Source

Operating margin

-0.29%

2024 Q2 · %

Exact inputs and evidence

Operating Income: -77000 USD Source
Revenue: 27000000 USD Source

Cash and cash equivalents: 10.8 million USD 2024-06-30 Source
Exact value

10828000 USD
Long-term debt including current maturities: 42.5 million USD 2019-12-31 Source
Exact value

42500000 USD
Shares outstanding: 52.4 million shares 2024-06-30 Source
Exact value

52387763 shares

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2024-08-07.

Financial data available through: 2023-12-31.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 2023-12-31
Operating income: 5 of 11 periods available· newest 2023-12-31
Net income: 5 of 11 periods available· newest 2023-12-31
Operating cash flow: 5 of 11 periods available· newest 2023-12-31
Capital expenditure: 5 of 11 periods available· newest 2023-12-31
Total assets: Multiple units; comparison withheld· newest 2023-12-31
Total liabilities: Multiple units; comparison withheld· newest 2023-12-31
Current assets: Multiple units; comparison withheld· newest 2023-12-31
Current liabilities: Multiple units; comparison withheld· newest 2023-12-31
Cash and cash equivalents: Multiple units; comparison withheld· newest 2023-12-31
Long-term debt including current maturities: 5 of 11 periods available· newest 2019-12-31
Shares outstanding: Multiple units; comparison withheld· newest 2023-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+49.2%

Prior period

Unit1 54.13 million

2022-01-01 – 2022-12-31
Current period

Unit1 80.75 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

80754000 − 54129000 = 26625000 Unit1

54129000 Unit1 · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
80754000 Unit1 · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · ALIMERA SCIENCES INC · 2023-12-31 ALIMERA SCIENCES INC (edgar:1267602) Year-over-year change in Revenue: 26625000 Unit1 Concept: fundies:Revenue Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:04:29Z Snapshot: eb98d2ab59860270be1f41733f7434071aac82c7a7cc78c98d503353057d8c2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1267602?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 80754000 Unit1 (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1267602/000126760224000019/alim-20231231x10k.htm#4307707 Filing: 000126760224000019 Input fundies:Revenue: 54129000 Unit1 (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1267602/000126760224000019/alim-20231231x10k.htm#1781918 Filing: 000126760224000019
The citation records this snapshot. The page link may show a newer release later.
Net income
−Unit1 2.03 million

Prior period

−Unit1 18.11 million

2022-01-01 – 2022-12-31
Current period

−Unit1 20.13 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

-20132000 − -18107000 = -2025000 Unit1

-18107000 Unit1 · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
-20132000 Unit1 · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ALIMERA SCIENCES INC · 2023-12-31 ALIMERA SCIENCES INC (edgar:1267602) Year-over-year change in Net income: -2025000 Unit1 Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:04:29Z Snapshot: eb98d2ab59860270be1f41733f7434071aac82c7a7cc78c98d503353057d8c2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1267602?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -20132000 Unit1 (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1267602/000126760224000019/alim-20231231x10k.htm#2414015 Filing: 000126760224000019 Input fundies:NetIncome: -18107000 Unit1 (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1267602/000126760224000019/alim-20231231x10k.htm#2416236 Filing: 000126760224000019
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−Unit1 4.29 million

Prior period

−Unit1 9.98 million

2022-01-01 – 2022-12-31
Current period

−Unit1 14.26 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

-14261000 − -9975000 = -4286000 Unit1

-9975000 Unit1 · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
-14261000 Unit1 · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ALIMERA SCIENCES INC · 2023-12-31 ALIMERA SCIENCES INC (edgar:1267602) Year-over-year change in Operating cash flow: -4286000 Unit1 Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:04:29Z Snapshot: eb98d2ab59860270be1f41733f7434071aac82c7a7cc78c98d503353057d8c2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1267602?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -14261000 Unit1 (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1267602/000126760224000019/alim-20231231x10k.htm#2488946 Filing: 000126760224000019 Input fundies:OperatingCashFlow: -9975000 Unit1 (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1267602/000126760224000019/alim-20231231x10k.htm#2491174 Filing: 000126760224000019
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+2%

Prior period

Unit1 255,000

2022-01-01 – 2022-12-31
Current period

Unit1 260,000

2023-01-01 – 2023-12-31

Exact inputs and evidence

260000 − 255000 = 5000 Unit1

255000 Unit1 · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
260000 Unit1 · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · ALIMERA SCIENCES INC · 2023-12-31 ALIMERA SCIENCES INC (edgar:1267602) Year-over-year change in Capital expenditure: 5000 Unit1 Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:04:29Z Snapshot: eb98d2ab59860270be1f41733f7434071aac82c7a7cc78c98d503353057d8c2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1267602?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 260000 Unit1 (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1267602/000126760224000019/alim-20231231x10k.htm#2496860 Filing: 000126760224000019 Input fundies:CapitalExpenditure: 255000 Unit1 (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1267602/000126760224000019/alim-20231231x10k.htm#2499058 Filing: 000126760224000019
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2023 2023-01-01 – 2023-12-31

Revenue Unit1 80.75 million 100% of revenue
Cost of revenue Unit1 10.84 million 13% of revenue
Operating expenses Unit1 71.85 million 89% of revenue
Operating income −Unit1 1.93 million −2.4% of revenue
Tax, interest and other Derived Unit1 18.2 million 23% of revenue
Net income −Unit1 20.13 million −25% of revenue

Cash

Operating cash flow −Unit1 14.26 million −18% of revenue
Capital expenditure Unit1 260,000 0.3% of revenue
Free cash flow Derived −Unit1 14.52 million −18% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2019 Operating loss: operating costs were 110% of revenue.
2020 Operating loss: operating costs were 101% of revenue.
2021 Operating loss: operating costs were 100% of revenue.
2022 Operating loss: operating costs were 122% of revenue.
2023 Operating loss: operating costs were 102% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2019 2019-01-01 – 2019-12-31	53943000	59217000 Derived	-5274000	5169000 Derived	-10443000	-4326000 Derived	Source 2019-01-01 – 2019-12-31: 53943000 Unit1 Inspect Revenue Open source 2019-01-01 – 2019-12-31: -5274000 Unit1 Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -10443000 Unit1 Inspect Net Income Open source 2019-01-01 – 2019-12-31: -4152000 Unit1 Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 174000 Unit1 Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	50820000	51321000 Derived	-501000	4838000 Derived	-5339000	-2813000 Derived	Source 2020-01-01 – 2020-12-31: 50820000 Unit1 Inspect Revenue Open source 2020-01-01 – 2020-12-31: -501000 Unit1 Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -5339000 Unit1 Inspect Net Income Open source 2020-01-01 – 2020-12-31: -2193000 Unit1 Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 620000 Unit1 Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	59029000	59230000 Derived	-201000	4171000 Derived	-4372000	-3845000 Derived	Source 2021-01-01 – 2021-12-31: 59029000 Unit1 Inspect Revenue Open source 2021-01-01 – 2021-12-31: -201000 Unit1 Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -4372000 Unit1 Inspect Net Income Open source 2021-01-01 – 2021-12-31: -3224000 Unit1 Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 621000 Unit1 Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	54129000	65769000 Derived	-11640000	6467000 Derived	-18107000	-10230000 Derived	Source 2022-01-01 – 2022-12-31: 54129000 Unit1 Inspect Revenue Open source 2022-01-01 – 2022-12-31: -11640000 Unit1 Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -18107000 Unit1 Inspect Net Income Open source 2022-01-01 – 2022-12-31: -9975000 Unit1 Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 255000 Unit1 Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	80754000	82686000 Derived	-1932000	18200000 Derived	-20132000	-14521000 Derived	Source 2023-01-01 – 2023-12-31: 80754000 Unit1 Inspect Revenue Open source 2023-01-01 – 2023-12-31: -1932000 Unit1 Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -20132000 Unit1 Inspect Net Income Open source 2023-01-01 – 2023-12-31: -14261000 Unit1 Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 260000 Unit1 Inspect Capital Expenditure Open source

Amounts are exact, in Unit1.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Unit1 80.8M 2023

Values and sources

Revenue values and source evidence
Period	Series	Value(Unit1)	Source evidence
20192019-12-31	Revenue	53943000	Revenue: 53943000 Open source
20202020-12-31	Revenue	50820000	Revenue: 50820000 Open source
20212021-12-31	Revenue	59029000	Revenue: 59029000 Open source
20222022-12-31	Revenue	54129000	Revenue: 54129000 Open source
20232023-12-31	Revenue	80754000	Revenue: 80754000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

49.2% 2023

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Year over year	No prior comparable period	Revenue: 53943000 Open source
20202020-12-31	Year over year	-5.8%	Revenue: 50820000 Open source Revenue: 53943000 Open source
20212021-12-31	Year over year	16.2%	Revenue: 59029000 Open source Revenue: 50820000 Open source
20222022-12-31	Year over year	-8.3%	Revenue: 54129000 Open source Revenue: 59029000 Open source
20232023-12-31	Year over year	49.2%	Revenue: 80754000 Open source Revenue: 54129000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -2.4% 2023

Net margin -24.9% 2023

Free cash flow margin -18% 2023

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Operating margin	-9.8%	Operating Income: -5274000 Open source Revenue: 53943000 Open source
20202020-12-31	Operating margin	-1%	Operating Income: -501000 Open source Revenue: 50820000 Open source
20212021-12-31	Operating margin	-0.3%	Operating Income: -201000 Open source Revenue: 59029000 Open source
20222022-12-31	Operating margin	-21.5%	Operating Income: -11640000 Open source Revenue: 54129000 Open source
20232023-12-31	Operating margin	-2.4%	Operating Income: -1932000 Open source Revenue: 80754000 Open source
20192019-12-31	Net margin	-19.4%	Net Income: -10443000 Open source Revenue: 53943000 Open source
20202020-12-31	Net margin	-10.5%	Net Income: -5339000 Open source Revenue: 50820000 Open source
20212021-12-31	Net margin	-7.4%	Net Income: -4372000 Open source Revenue: 59029000 Open source
20222022-12-31	Net margin	-33.5%	Net Income: -18107000 Open source Revenue: 54129000 Open source
20232023-12-31	Net margin	-24.9%	Net Income: -20132000 Open source Revenue: 80754000 Open source
20192019-12-31	Free cash flow margin	-8%	Revenue: 53943000 Open source Operating Cash Flow: -4152000 Open source Capital Expenditure: 174000 Open source
20202020-12-31	Free cash flow margin	-5.5%	Revenue: 50820000 Open source Operating Cash Flow: -2193000 Open source Capital Expenditure: 620000 Open source
20212021-12-31	Free cash flow margin	-6.5%	Revenue: 59029000 Open source Operating Cash Flow: -3224000 Open source Capital Expenditure: 621000 Open source
20222022-12-31	Free cash flow margin	-18.9%	Revenue: 54129000 Open source Operating Cash Flow: -9975000 Open source Capital Expenditure: 255000 Open source
20232023-12-31	Free cash flow margin	-18%	Revenue: 80754000 Open source Operating Cash Flow: -14261000 Open source Capital Expenditure: 260000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

Unit1 -14.3M 2023

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(Unit1)	Source evidence
20192019-12-31	Operating cash flow	-4152000	Operating Cash Flow: -4152000 Open source
20202020-12-31	Operating cash flow	-2193000	Operating Cash Flow: -2193000 Open source
20212021-12-31	Operating cash flow	-3224000	Operating Cash Flow: -3224000 Open source
20222022-12-31	Operating cash flow	-9975000	Operating Cash Flow: -9975000 Open source
20232023-12-31	Operating cash flow	-14261000	Operating Cash Flow: -14261000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Unit1 -14.5M 2023

Values and sources

Free cash flow values and source evidence
Period	Series	Value(Unit1)	Source evidence
20192019-12-31	Free cash flow	-4326000	Operating Cash Flow: -4152000 Open source Capital Expenditure: 174000 Open source
20202020-12-31	Free cash flow	-2813000	Operating Cash Flow: -2193000 Open source Capital Expenditure: 620000 Open source
20212021-12-31	Free cash flow	-3845000	Operating Cash Flow: -3224000 Open source Capital Expenditure: 621000 Open source
20222022-12-31	Free cash flow	-10230000	Operating Cash Flow: -9975000 Open source Capital Expenditure: 255000 Open source
20232023-12-31	Free cash flow	-14521000	Operating Cash Flow: -14261000 Open source Capital Expenditure: 260000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2019-12-31	Liabilities / assets	Not reported	No source recorded
2020-12-31	Liabilities / assets	Not reported	No source recorded
2021-12-31	Liabilities / assets	Not reported	No source recorded
2022-12-31	Liabilities / assets	Not reported	No source recorded
2023-12-31	Liabilities / assets	Not reported	No source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2019-12-31	Current assets / current liabilities	Not reported	No source recorded
2020-12-31	Current assets / current liabilities	Not reported	No source recorded
2021-12-31	Current assets / current liabilities	Not reported	No source recorded
2022-12-31	Current assets / current liabilities	Not reported	No source recorded
2023-12-31	Current assets / current liabilities	Not reported	No source recorded

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2019 2019-01-01 – 2019-12-31	−Unit1 10.44 million Exact value Exact value: -10443000 Unit1 2019-01-01 – 2019-12-31: -10443000 Unit1 Inspect Net Income Open source Share or cite Citation for Net Income · ALIMERA SCIENCES INC · 2019-12-31 ALIMERA SCIENCES INC (edgar:1267602) Net Income: -10443000 Unit1 Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:04:29Z Snapshot: eb98d2ab59860270be1f41733f7434071aac82c7a7cc78c98d503353057d8c2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1267602/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=Unit1&dimensions= Input fundies:NetIncome: -10443000 Unit1 (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1267602/000126760221000013/alim-20201231x10k.htm#2318436 Filing: 000126760221000013 The citation records this snapshot. The page link may show a newer release later.	−Unit1 4.15 million Exact value Exact value: -4152000 Unit1 2019-01-01 – 2019-12-31: -4152000 Unit1 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALIMERA SCIENCES INC · 2019-12-31 ALIMERA SCIENCES INC (edgar:1267602) Operating Cash Flow: -4152000 Unit1 Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:04:29Z Snapshot: eb98d2ab59860270be1f41733f7434071aac82c7a7cc78c98d503353057d8c2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1267602/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=Unit1&dimensions= Input fundies:OperatingCashFlow: -4152000 Unit1 (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1267602/000126760221000013/alim-20201231x10k.htm#2377509 Filing: 000126760221000013 The citation records this snapshot. The page link may show a newer release later.	Unit1 174,000 Exact value Exact value: 174000 Unit1 2019-01-01 – 2019-12-31: 174000 Unit1 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALIMERA SCIENCES INC · 2019-12-31 ALIMERA SCIENCES INC (edgar:1267602) Capital Expenditure: 174000 Unit1 Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:04:29Z Snapshot: eb98d2ab59860270be1f41733f7434071aac82c7a7cc78c98d503353057d8c2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1267602/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=Unit1&dimensions= Input fundies:CapitalExpenditure: 174000 Unit1 (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1267602/000126760221000013/alim-20201231x10k.htm#2385429 Filing: 000126760221000013 The citation records this snapshot. The page link may show a newer release later.	−Unit1 4.33 million Calculation and evidence -4152000 − 174000 Unit1 Exact free cash flow: -4326000 Unit1 2019-01-01 – 2019-12-31: -4152000 Unit1 · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 174000 Unit1 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALIMERA SCIENCES INC · 2019-12-31 ALIMERA SCIENCES INC (edgar:1267602) Free cash flow: -4326000 Unit1 Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:04:29Z Snapshot: eb98d2ab59860270be1f41733f7434071aac82c7a7cc78c98d503353057d8c2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1267602?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4152000 Unit1 (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1267602/000126760221000013/alim-20201231x10k.htm#2377509 Filing: 000126760221000013 Input fundies:CapitalExpenditure: 174000 Unit1 (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1267602/000126760221000013/alim-20201231x10k.htm#2385429 Filing: 000126760221000013 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−Unit1 5.34 million Exact value Exact value: -5339000 Unit1 2020-01-01 – 2020-12-31: -5339000 Unit1 Inspect Net Income Open source Share or cite Citation for Net Income · ALIMERA SCIENCES INC · 2020-12-31 ALIMERA SCIENCES INC (edgar:1267602) Net Income: -5339000 Unit1 Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:04:29Z Snapshot: eb98d2ab59860270be1f41733f7434071aac82c7a7cc78c98d503353057d8c2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1267602/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=Unit1&dimensions= Input fundies:NetIncome: -5339000 Unit1 (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1267602/000126760222000013/alim-20211231x10k.htm#2229431 Filing: 000126760222000013 The citation records this snapshot. The page link may show a newer release later.	−Unit1 2.19 million Exact value Exact value: -2193000 Unit1 2020-01-01 – 2020-12-31: -2193000 Unit1 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALIMERA SCIENCES INC · 2020-12-31 ALIMERA SCIENCES INC (edgar:1267602) Operating Cash Flow: -2193000 Unit1 Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:04:29Z Snapshot: eb98d2ab59860270be1f41733f7434071aac82c7a7cc78c98d503353057d8c2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1267602/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=Unit1&dimensions= Input fundies:OperatingCashFlow: -2193000 Unit1 (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1267602/000126760222000013/alim-20211231x10k.htm#2300435 Filing: 000126760222000013 The citation records this snapshot. The page link may show a newer release later.	Unit1 620,000 Exact value Exact value: 620000 Unit1 2020-01-01 – 2020-12-31: 620000 Unit1 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALIMERA SCIENCES INC · 2020-12-31 ALIMERA SCIENCES INC (edgar:1267602) Capital Expenditure: 620000 Unit1 Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:04:29Z Snapshot: eb98d2ab59860270be1f41733f7434071aac82c7a7cc78c98d503353057d8c2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1267602/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=Unit1&dimensions= Input fundies:CapitalExpenditure: 620000 Unit1 (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1267602/000126760222000013/alim-20211231x10k.htm#2308307 Filing: 000126760222000013 The citation records this snapshot. The page link may show a newer release later.	−Unit1 2.81 million Calculation and evidence -2193000 − 620000 Unit1 Exact free cash flow: -2813000 Unit1 2020-01-01 – 2020-12-31: -2193000 Unit1 · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 620000 Unit1 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALIMERA SCIENCES INC · 2020-12-31 ALIMERA SCIENCES INC (edgar:1267602) Free cash flow: -2813000 Unit1 Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:04:29Z Snapshot: eb98d2ab59860270be1f41733f7434071aac82c7a7cc78c98d503353057d8c2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1267602?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2193000 Unit1 (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1267602/000126760222000013/alim-20211231x10k.htm#2300435 Filing: 000126760222000013 Input fundies:CapitalExpenditure: 620000 Unit1 (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1267602/000126760222000013/alim-20211231x10k.htm#2308307 Filing: 000126760222000013 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−Unit1 4.37 million Exact value Exact value: -4372000 Unit1 2021-01-01 – 2021-12-31: -4372000 Unit1 Inspect Net Income Open source Share or cite Citation for Net Income · ALIMERA SCIENCES INC · 2021-12-31 ALIMERA SCIENCES INC (edgar:1267602) Net Income: -4372000 Unit1 Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:04:29Z Snapshot: eb98d2ab59860270be1f41733f7434071aac82c7a7cc78c98d503353057d8c2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1267602/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=Unit1&dimensions= Input fundies:NetIncome: -4372000 Unit1 (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1267602/000126760223000027/alim-20221231x10k.htm#2233345 Filing: 000126760223000027 The citation records this snapshot. The page link may show a newer release later.	−Unit1 3.22 million Exact value Exact value: -3224000 Unit1 2021-01-01 – 2021-12-31: -3224000 Unit1 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALIMERA SCIENCES INC · 2021-12-31 ALIMERA SCIENCES INC (edgar:1267602) Operating Cash Flow: -3224000 Unit1 Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:04:29Z Snapshot: eb98d2ab59860270be1f41733f7434071aac82c7a7cc78c98d503353057d8c2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1267602/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=Unit1&dimensions= Input fundies:OperatingCashFlow: -3224000 Unit1 (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1267602/000126760223000027/alim-20221231x10k.htm#2304443 Filing: 000126760223000027 The citation records this snapshot. The page link may show a newer release later.	Unit1 621,000 Exact value Exact value: 621000 Unit1 2021-01-01 – 2021-12-31: 621000 Unit1 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALIMERA SCIENCES INC · 2021-12-31 ALIMERA SCIENCES INC (edgar:1267602) Capital Expenditure: 621000 Unit1 Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:04:29Z Snapshot: eb98d2ab59860270be1f41733f7434071aac82c7a7cc78c98d503353057d8c2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1267602/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=Unit1&dimensions= Input fundies:CapitalExpenditure: 621000 Unit1 (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1267602/000126760223000027/alim-20221231x10k.htm#2312315 Filing: 000126760223000027 The citation records this snapshot. The page link may show a newer release later.	−Unit1 3.85 million Calculation and evidence -3224000 − 621000 Unit1 Exact free cash flow: -3845000 Unit1 2021-01-01 – 2021-12-31: -3224000 Unit1 · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 621000 Unit1 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALIMERA SCIENCES INC · 2021-12-31 ALIMERA SCIENCES INC (edgar:1267602) Free cash flow: -3845000 Unit1 Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:04:29Z Snapshot: eb98d2ab59860270be1f41733f7434071aac82c7a7cc78c98d503353057d8c2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1267602?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3224000 Unit1 (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1267602/000126760223000027/alim-20221231x10k.htm#2304443 Filing: 000126760223000027 Input fundies:CapitalExpenditure: 621000 Unit1 (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1267602/000126760223000027/alim-20221231x10k.htm#2312315 Filing: 000126760223000027 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−Unit1 18.11 million Exact value Exact value: -18107000 Unit1 2022-01-01 – 2022-12-31: -18107000 Unit1 Inspect Net Income Open source Share or cite Citation for Net Income · ALIMERA SCIENCES INC · 2022-12-31 ALIMERA SCIENCES INC (edgar:1267602) Net Income: -18107000 Unit1 Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:04:29Z Snapshot: eb98d2ab59860270be1f41733f7434071aac82c7a7cc78c98d503353057d8c2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1267602/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=Unit1&dimensions= Input fundies:NetIncome: -18107000 Unit1 (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1267602/000126760224000019/alim-20231231x10k.htm#2416236 Filing: 000126760224000019 The citation records this snapshot. The page link may show a newer release later.	−Unit1 9.98 million Exact value Exact value: -9975000 Unit1 2022-01-01 – 2022-12-31: -9975000 Unit1 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALIMERA SCIENCES INC · 2022-12-31 ALIMERA SCIENCES INC (edgar:1267602) Operating Cash Flow: -9975000 Unit1 Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:04:29Z Snapshot: eb98d2ab59860270be1f41733f7434071aac82c7a7cc78c98d503353057d8c2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1267602/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=Unit1&dimensions= Input fundies:OperatingCashFlow: -9975000 Unit1 (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1267602/000126760224000019/alim-20231231x10k.htm#2491174 Filing: 000126760224000019 The citation records this snapshot. The page link may show a newer release later.	Unit1 255,000 Exact value Exact value: 255000 Unit1 2022-01-01 – 2022-12-31: 255000 Unit1 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALIMERA SCIENCES INC · 2022-12-31 ALIMERA SCIENCES INC (edgar:1267602) Capital Expenditure: 255000 Unit1 Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:04:29Z Snapshot: eb98d2ab59860270be1f41733f7434071aac82c7a7cc78c98d503353057d8c2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1267602/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=Unit1&dimensions= Input fundies:CapitalExpenditure: 255000 Unit1 (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1267602/000126760224000019/alim-20231231x10k.htm#2499058 Filing: 000126760224000019 The citation records this snapshot. The page link may show a newer release later.	−Unit1 10.23 million Calculation and evidence -9975000 − 255000 Unit1 Exact free cash flow: -10230000 Unit1 2022-01-01 – 2022-12-31: -9975000 Unit1 · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 255000 Unit1 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALIMERA SCIENCES INC · 2022-12-31 ALIMERA SCIENCES INC (edgar:1267602) Free cash flow: -10230000 Unit1 Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:04:29Z Snapshot: eb98d2ab59860270be1f41733f7434071aac82c7a7cc78c98d503353057d8c2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1267602?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9975000 Unit1 (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1267602/000126760224000019/alim-20231231x10k.htm#2491174 Filing: 000126760224000019 Input fundies:CapitalExpenditure: 255000 Unit1 (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1267602/000126760224000019/alim-20231231x10k.htm#2499058 Filing: 000126760224000019 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−Unit1 20.13 million Exact value Exact value: -20132000 Unit1 2023-01-01 – 2023-12-31: -20132000 Unit1 Inspect Net Income Open source Share or cite Citation for Net Income · ALIMERA SCIENCES INC · 2023-12-31 ALIMERA SCIENCES INC (edgar:1267602) Net Income: -20132000 Unit1 Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:04:29Z Snapshot: eb98d2ab59860270be1f41733f7434071aac82c7a7cc78c98d503353057d8c2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1267602/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=Unit1&dimensions= Input fundies:NetIncome: -20132000 Unit1 (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1267602/000126760224000019/alim-20231231x10k.htm#2414015 Filing: 000126760224000019 The citation records this snapshot. The page link may show a newer release later.	−Unit1 14.26 million Exact value Exact value: -14261000 Unit1 2023-01-01 – 2023-12-31: -14261000 Unit1 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALIMERA SCIENCES INC · 2023-12-31 ALIMERA SCIENCES INC (edgar:1267602) Operating Cash Flow: -14261000 Unit1 Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:04:29Z Snapshot: eb98d2ab59860270be1f41733f7434071aac82c7a7cc78c98d503353057d8c2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1267602/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=Unit1&dimensions= Input fundies:OperatingCashFlow: -14261000 Unit1 (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1267602/000126760224000019/alim-20231231x10k.htm#2488946 Filing: 000126760224000019 The citation records this snapshot. The page link may show a newer release later.	Unit1 260,000 Exact value Exact value: 260000 Unit1 2023-01-01 – 2023-12-31: 260000 Unit1 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALIMERA SCIENCES INC · 2023-12-31 ALIMERA SCIENCES INC (edgar:1267602) Capital Expenditure: 260000 Unit1 Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:04:29Z Snapshot: eb98d2ab59860270be1f41733f7434071aac82c7a7cc78c98d503353057d8c2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1267602/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=Unit1&dimensions= Input fundies:CapitalExpenditure: 260000 Unit1 (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1267602/000126760224000019/alim-20231231x10k.htm#2496860 Filing: 000126760224000019 The citation records this snapshot. The page link may show a newer release later.	−Unit1 14.52 million Calculation and evidence -14261000 − 260000 Unit1 Exact free cash flow: -14521000 Unit1 2023-01-01 – 2023-12-31: -14261000 Unit1 · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 260000 Unit1 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALIMERA SCIENCES INC · 2023-12-31 ALIMERA SCIENCES INC (edgar:1267602) Free cash flow: -14521000 Unit1 Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:04:29Z Snapshot: eb98d2ab59860270be1f41733f7434071aac82c7a7cc78c98d503353057d8c2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1267602?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -14261000 Unit1 (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1267602/000126760224000019/alim-20231231x10k.htm#2488946 Filing: 000126760224000019 Input fundies:CapitalExpenditure: 260000 Unit1 (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1267602/000126760224000019/alim-20231231x10k.htm#2496860 Filing: 000126760224000019 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

72 filings · 5,205 latest values · 5,205 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001267602, 1267602, ALIM, edgar:1267602

Also known as ALIMERA SCIENCES INC, ALIMERA SCIENCES, INC., Alimera Sciences, Inc.

ALIMERA SCIENCES INC

Latest quarter

Revenue

Operating margin

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2023 2023-01-01 – 2023-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation